Acurx Pharmaceuticals
ACXP
ACXP
16 hedge funds and large institutions have $247K invested in Acurx Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
83% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 18
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$80.4K | |
| 2 | +$44K | |
| 3 | +$30.4K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$27.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.24K |
Top Sellers
| 1 | -$551K | |
| 2 | -$74.8K | |
| 3 | -$74.4K | |
| 4 |
Renaissance Technologies
New York
|
-$44.8K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$43K |